Dennis Kasper

Last updated
Dennis L. Kasper
BornFebruary 23, 1943
Chicago, Illinois
CitizenshipUnited States
Alma materUniversity of Illinois, Urbana
SpouseMarie Scurti
Awards
Scientific career
Fields Microbiology, immunology
InstitutionsHarvard Medical School
Website kasperlab.hms.harvard.edu

Dennis L. Kasper (born February 23, 1943) is an American microbiologist and immunologist, and the William Ellery Channing Professor of Medicine and Professor of Immunology at Harvard Medical School. He leads the Kasper Laboratory within the Blavatnik Institute in the Department of Immunology at Harvard Medical School. He was also executive dean for academic programs at Harvard Medical School and director of the Channing Laboratory Department of Medicine at Brigham and Women's Hospital. [1]

Contents

Kasper is known for his research in interactions of the microbiome and immune system, and his work has played a key role in bringing modern molecular and chemical biology into understanding the role microbes have in development and regulation of the immune system. His primary focus is on immunochemistry alongside the genetics of bacteria and their role in virulence – research that has concentrated on topics related to bacterial polysaccharides and glycolipids. [2] Kasper is also known as editor (alongside Anthony Fauci, Stephen L. Hauser and others) of Harrison's Principles of Internal Medicine – a book widely used by medical schools and practicing physicians.

Work and life

Kasper was born on February 23, 1943, in Chicago, Illinois to first-generation American parents. He was the first in his family to attend college, going to the University of Illinois, Urbana on a pre-med track, and graduating in 1963 having majored in zoology. [2] [3] Kasper completed his medical training at both the University of Illinois College of Medicine, Chicago (graduating in 1967), New York Hospital  (Cornell Medical Center) and Peter Bent Brigham Hospital (Brigham and Women's Hospital at Harvard Medical School). He began his research career at the Walter Reed Army Institute of Research from 1969 to 1972. [3] He became an Albee Fellow at Harvard Medical School in 1973, and from 1979 to 1985 was an associate professor of medicine at Harvard Medical School. [4] He later received an honorary Master's of Arts degree from Harvard University in 1986. [5]

Kasper was director of the Channing Laboratory at Brigham and Women's Hospital from 1996 to 2012, and has been William Ellery Channing Professor of Medicine and Professor of Microbiology and Immunology at Harvard Medical School since 1989. [6] He was also the scientific director at the New England Center of Excellence in Biodefense and Emerging Infectious Diseases at Harvard Medical School until 2014. [7] [8] Between 2002 and 2004, Kasper was President of the International Society of Infectious Diseases, and Kasper was the first chairman of the National Science Advisory Board of Biosecurity from 2005 to 2010. [9] [10] He also served as Chairman of Scientific Counselors at the National Institute of Allergy and Infectious Diseases between 1989 and 1993.

Research

Kasper's research has focused on immunochemistry, and has played a large role in the understanding of the role of the microbiota in the development of the immune system. Kasper's key research has included the identification of immunomodulatory molecules from the microbiome, and exploration of how these are used to treat immune-mediated diseases.

Microbes and the immune system

Kasper's research included elucidating the structure of the nine capsular polysaccharides of B Streptococcus (GBS). [11] [12] His work formed much of the understanding of the pathogenesis of GBS infection, and led to the development of vaccines for 5 major serotypes of the group. [13] [14] This work was instrumental in defining the 'mechanisms by which conjugate vaccines stimulate the immune system'. [15] Kasper also led the discovery and development of glycoconjugate vaccines, currently in clinical trials, for preventing group B streptococcal infections. [16]

Kasper's study of Bacteroides fragilis was fundamental to developing the understanding of relationship between gut microbiota and the immune system. [17] [18] His work on exploring the links between the two led to Kasper's election to the National Academy of Medicine in 2001, the American Academy of Microbiology in 2005, and the National Academy of Sciences in 2018.

His discovery of polysaccharide A of B. fragilis and further work relating to the development and regulation of the immune system by specific microbial molecules built upon the hygiene hypothesis, holding that exposure to microbes at an early age is critical to building a healthy immune system.

Immunomodulatory research

Kasper's research in the space of sphingolipids led his group to discover B. fragilis glycosphingolipids, which modulate natural killer T cell mediated inflammation in the colon; this alongside the polysaccharide A work were the first immunomodulatory molecules identified from the microbiome. [19] Kasper noted "Such molecules are hard to find [...] It’s because the technology required to do it requires bacteriology, immunology, chemistry, and genetics. Most [laboratories] specialize in one or the other. We do a little of everything to mechanistically understand how microbial molecules interact with the immune system." [20]

Related Research Articles

Biodefense refers to measures to counter biological threats, reduce biological risks, and prepare for, respond to, and recover from bioincidents, whether naturally occurring, accidental, or deliberate in origin and whether impacting human, animal, plant, or environmental health. Biodefense measures often aim to improve biosecurity or biosafety. Biodefense is frequently discussed in the context of biological warfare or bioterrorism, and is generally considered a military or emergency response term.

<span class="mw-page-title-main">American Society for Microbiology</span> American scholarly society focused on microbiology

The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<i>Bacteroides fragilis</i> Species of bacterium

Bacteroides fragilis is an anaerobic, Gram-negative, pleomorphic to rod-shaped bacterium. It is part of the normal microbiota of the human colon and is generally commensal, but can cause infection if displaced into the bloodstream or surrounding tissue following surgery, disease, or trauma.

Gerald Domingue is an American medical researcher and academic who served as Professor of Urology, Microbiology and Immunology in the Tulane University School of Medicine and Graduate School for thirty years and also as Director of Research in Urology. He is currently retired and resides in Zürich, Switzerland, where he is engaged in painting and creative writing. At retirement he was honored with the title of Professor Emeritus at Tulane (1967–1997). Prior to Tulane, he was faculty of Saint Louis University School of Medicine); was a lecturer at Washington University School of Dentistry and director of clinical microbiology in St. Louis City Hospital, St. Louis, Missouri.

John Bennett Robbins was a senior investigator at the National Institutes of Health (NIH), best known for his contribution to the development of the vaccine against bacterial meningitis Hib)) with his colleague Rachel Schneerson. He conducted research on the Bethesda, Maryland campus of the NIH from 1970 until his retirement at the age of 80 in 2012. During his tenure, he worked in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Food and Drug Administration’s biologics laboratories on location.

<span class="mw-page-title-main">Microbial symbiosis and immunity</span>

Long-term close-knit interactions between symbiotic microbes and their host can alter host immune system responses to other microorganisms, including pathogens, and are required to maintain proper homeostasis. The immune system is a host defense system consisting of anatomical physical barriers as well as physiological and cellular responses, which protect the host against harmful microorganisms while limiting host responses to harmless symbionts. Humans are home to 1013 to 1014 bacteria, roughly equivalent to the number of human cells, and while these bacteria can be pathogenic to their host most of them are mutually beneficial to both the host and bacteria.

Lynn Bry is a physician, anaerobic microbiologist, and microbial geneticist at Brigham & Women's Hospital, and Harvard Medical School. She has created multiple multi-institutional platforms to support scientific, clinical and educational activities, including the MadSci Network, Crimson prospective collection resource, Massachusetts Host-Microbiome Center, and Partners Healthcare-wide Pathogen Genomic Surveillance Program. She has also founded or co-founded successful start-up companies including iSpecimen and ConsortiaTX. She was awarded her MD and a PhD in Molecular Microbiology and Pathogenesis from Washington University School of Medicine. Her research studies host-microbiome interactions and their application to develop new therapeutics for human disease. She has authored or co-authored >70 peer-reviewed articles and book chapters, including original papers in Science detailing a molecular model of host-microbial cross-talk in the small intestine, and in Nature Medicine demonstrate therapeutic use of defined commensal microbes to reverse food allergies. Bry teaches medical school courses and is also a lecturer and mentor for the Project Success Program at Harvard Medical School.

<span class="mw-page-title-main">Edward Thomas Ryan</span> American microbiologist

Edward Thomas Ryan is an American microbiologist, immunologist, and physician at Harvard University and Massachusetts General Hospital. Ryan served as president of the American Society of Tropical Medicine and Hygiene from 2009 to 2010. Ryan is Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of Global Infectious Diseases at the Massachusetts General Hospital. Ryan's research and clinical focus has been on infectious diseases associated with residing in, immigrating from, or traveling through resource-limited areas. Ryan is a Fellow of the American Society of Microbiology, the American Society of Tropical Medicine and Hygiene, the American College of Physicians, and the Infectious Diseases Society of America.

<span class="mw-page-title-main">Rachel Schneerson</span> Israeli-American vaccinologist

Rachel Schneerson is a former senior investigator in the Laboratory in Developmental and Molecular Immunity and head of the Section on Bacterial Disease Pathogens and Immunity within the Laboratory at the Eunice Kennedy Shriver National Institute of Child Health and Human Development within the National Institutes of Health. She is best known for her development of the vaccine against bacterial meningitis with her colleague John B. Robbins.

Sarkis Mazmanian is an American medical microbiologist who has served as a professor at the California Institute of Technology since 2006. He is currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering, and a board member of Seed. Prior to this, Mazmanian was affiliated with Harvard Medical School and the University of Chicago. In 2012, Mazmanian was awarded a MacArthur Fellowship for his pioneering work on the human microbiome.

<span class="mw-page-title-main">David Relman</span> American microbiologist

David Arnold Relman is an American microbiologist and the Thomas C. and Joan M. Merigan Professor in Medicine, and in Microbiology & Immunology at the Stanford University School of Medicine. His research focuses on the human microbiome and microbial ecosystem—for which he was a pioneer in the use of modern molecular methods, as well as on pathogen discovery and the genomics of host response.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

<i>Bacteroides thetaiotaomicron</i> Species of bacterium

Bacteroides thetaiotaomicron is a gram-negative, rod shaped obligate anaerobic bacterium that is a prominent member of the normal gut microbiome in the distal intestines. Its proteome, consisting of 4,779 members, includes a system for obtaining and breaking down dietary polysaccharides that would otherwise be difficult to digest. B. thetaiotaomicron is also an opportunistic pathogen, meaning it may become virulent in immunocompromised individuals. It is often used in research as a model organism for functional studies of the human microbiota in the gut.

Dan Hung Barouch is an American physician, immunologist, and virologist. He is known for his work on the pathogenesis and immunology of viral infections and the development of vaccine strategies for global infectious diseases.

<span class="mw-page-title-main">Sarah Fortune</span> American immunologist

Sarah Merritt Fortune is an American immunologist. She is a Full Professor of Immunology and Infectious Diseases in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health.

Donald "Don" Emil Ganem is an American physician, virologist, professor emeritus of microbiology and medicine, and former global head of infectious disease research at Novartis Institutes for BioMedical Research (NIBR).

Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School, and currently Chief Medical Officer at eMed.

Dan M. Granoff is an infectious disease physician-scientist who was named the 2014 Maurice Hilleman/Merck Laureate by the American Society for Microbiology for outstanding contributions to vaccine discovery and development. Beginning in 2011, Granoff held the Clorox Foundation Endowed Chair and was director of the Center of Immunobiology and Vaccine Development at Children's Hospital Oakland Research Institute. His work increased understanding of basic mechanisms of human immunity to encapsulated bacteria, and furthered development of vaccines against Haemophilus influenzae type B (Hib) and Neisseria meningitidis.

<span class="mw-page-title-main">Wendy Garrett</span>

Wendy Sarah Garrett is an American microbiologist who is the Irene Heinz Given Professor of Immunology and Infectious Diseases at the Harvard Chan School of Public Health. She holds a joint position in the Departments of Medicine at Harvard Medical School.

References

  1. ↑ "Dennis L. Kasper, M.D." kasperlab.hms.harvard.edu. Retrieved 2022-09-27.
  2. 1 2 "Dennis L. Kasper · Maximizing Microbiology: Molecular Genetics, Cancer, and Virology, 1913–2013 · OnView: Digital Collections & Exhibits". collections.countway.harvard.edu. Retrieved 2022-09-27.
  3. 1 2 Viegas, Jennifer (2019-12-26). "Profile of Dennis L. Kasper". Proceedings of the National Academy of Sciences. 116 (52): 26144–26146. Bibcode:2019PNAS..11626144V. doi: 10.1073/pnas.1920088116 . ISSN   0027-8424. PMC   6936685 . PMID   31792193.
  4. ↑ Mumford, Heather. "Research Guides: Vaccines: An Evolving History: Archive & Manuscript Collections". guides.library.harvard.edu. Retrieved 2022-09-27.
  5. ↑ "ORCID – Dennis Kasper". orcid.org. Retrieved 2022-09-27.
  6. ↑ "Channing Division of Network Medicine History – Brigham and Women's Hospital". www.brighamandwomens.org. Retrieved 2022-09-27.
  7. ↑ "Biosecurity and Biodefense Resource – Federation of American Scientists". biosecurity.fas.org. Retrieved 2022-10-28.
  8. ↑ Nieuwkerk, Jennifer. "Harvard University Receives $9.8M NIH Grant". info.biotech-calendar.com. Retrieved 2022-10-28. Researchers at Harvard University received a $9.8 million grant from the NIH this year for the New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Research. The project leader is listed as Dr. Dennis Kasper. According to the Harvard University website, Dr. Kasper and his research team are interested in the interactions of microbes, including commensals and pathogens, with the immune system.
  9. ↑ Medicine, Institute of; Agency, Medical Follow-up; Program, Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research (2002-12-25). An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program. National Academies Press. ISBN   978-0-309-08626-4.
  10. ↑ The Journal of Immunology: Official Journal of the American Association of Immunologists. Williams & Wilkins. 2009.
  11. ↑ Welfare, United States Congress House Committee on Appropriations Subcommittee on the Departments of Labor and Health, Education, and (1979). Departments of Labor and Health, Education, and Welfare appropriations for 1980: hearings before a subcommittee of the Committee on Appropriations, House of Representatives, Ninety-sixth Congress, first session. U.S. Government Printing Office. p. 779.{{cite book}}: CS1 maint: multiple names: authors list (link)
  12. ↑ Tettelin, Hervé; Medini, Duccio (2020-04-30). The Pangenome: Diversity, Dynamics and Evolution of Genomes. Springer Nature. ISBN   978-3-030-38281-0.
  13. ↑ "Dennis L. Kasper, MD". highered.mheducation.com. Retrieved 2022-10-28.
  14. ↑ Ellis, Ronald W.; Brodeur, Bernard R. (2003-11-30). New Bacterial Vaccines. Springer Science & Business Media. ISBN   978-0-306-47832-1.
  15. ↑ Avci, Fikri Y.; Li, Xiangming; Tsuji, Moriya; Kasper, Dennis L. (December 2011). "A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design". Nature Medicine. 17 (12): 1602–1609. doi: 10.1038/nm.2535 . ISSN   1546-170X. PMC   3482454 . PMID   22101769. S2CID   195682634.
  16. ↑ Vaccines. Cold Spring Harbor Laboratory. 1994. ISBN   978-0-87969-434-0.
  17. ↑ McAdam, Alexander J. (2021-10-19). Munson, Erik (ed.). "Biographical Feature: Andrew B. Onderdonk, Ph.D." Journal of Clinical Microbiology. 59 (11): e01505–21. doi:10.1128/JCM.01505-21. ISSN   0095-1137. PMC   8525579 . PMID   34524890. Another major area of inquiry for Dr. Onderdonk, pursued in collaboration with Dr. Dennis Kasper, was the role of the capsule in the virulence of Bacteroides fragilis. Encapsulated, but not unencapsulated, strains caused abscess formation in the intra-abdominal sepsis model; furthermore, purified capsule also caused abscess formation (19).
  18. ↑ Winslow, Charles-Edward Amory; Sherman, James Morgan; Porter, John Roger (1979). Journal of Bacteriology. Vol. 138. American Society for Microbiology. p. 617. ISBN   978-0-914826-19-4.
  19. ↑ An, Dingding; Oh, Sungwhan F.; Olszak, Torsten; Neves, Joana F.; Avci, Fikri Y.; Erturk-Hasdemir, Deniz; Lu, Xi; Zeissig, Sebastian; Blumberg, Richard S.; Kasper, Dennis L. (January 2014). "Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells". Cell. 156 (1–2): 123–133. doi:10.1016/j.cell.2013.11.042. ISSN   0092-8674. PMC   3909465 . PMID   24439373.
  20. ↑ Viegas, Jennifer (2 December 2019). "Profile of Dennis L. Kasper". Proceedings of the National Academy of Sciences. 116 (52): 26144–26146. Bibcode:2019PNAS..11626144V. doi: 10.1073/pnas.1920088116 . ISSN   0027-8424. PMC   6936685 . PMID   31792193.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.